Nanopath Secures $10M to Develop POC Diagnostics for Women’s Health
Nanopath, a molecular diagnostics company enabling high-quality molecular testing in minutes, has closed $10 million in Series A funding that will support development and commercialization of the company’s biosensing platform that aims […]
Nanopath Secures $10M to Develop POC Diagnostics for Women’s Health Read More »